Search Results - Norihiko Yoshimura
- Showing 1 - 2 results of 2
-
1
Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction by Takuya Ozawa, Ken Toba, Hiroshi Suzuki, Kiminori Kato, Yoshitaka Iso, Yasushi Akutsu, Youichi Kobayashi, Youichi Takeyama, Naohiko Kobayashi, Norihiko Yoshimura, Kohei Akazawa, Yoshifusa Aizawa
Published 2010Artigo -
2
Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism by Yohko Yoshida, Ippei Shimizu, Atsuhiro Shimada, Keita Nakahara, Sachiko Yanagisawa, Minoru Kubo, Shinji Fukuda, Chiharu Ishii, Hiromitsu Yamamoto, Takamasa Ishikawa, Kuniyuki Kano, Junken Aoki, Goro Katsuumi, Masayoshi Suda, Kazuyuki Ozaki, Yutaka Yoshida, Shujiro Okuda, Shigeo Ohta, Shiki Okamoto, Yasuhiko Minokoshi, Kanako Oda, Toshikuni Sasaoka, Manabu Abe, Kenji Sakimura, Yoshiaki Kubota, Norihiko Yoshimura, Shingo Kajimura, María A. Zuriaga, Kenneth Walsh, Tomoyoshi Soga, Tohru Minamino
Published 2022Artigo
Search Tools:
Related Subjects
Heart failure
Internal medicine
Medicine
Adipose tissue
Biochemistry
Bioinformatics
Biology
Brown adipose tissue
Cardiology
Chemistry
Conventional PCI
Ejection fraction
Endocrinology
Epistemology
Erythropoietin
Mechanism (biology)
Myocardial infarction
Percutaneous coronary intervention
Philosophy
Trimethylamine
Trimethylamine N-oxide